Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2025-12-26 @ 4:00 AM
Study NCT ID:
NCT00783718
Status:
COMPLETED
Last Update Posted:
2014-07-18
First Post:
2008-10-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-01
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-31
First Submit QC Date:
None
Study First Post Date:
2008-11-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-06-19
Results First Submit QC Date:
None
Results First Post Date:
2014-07-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-01-23
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-06-19
Last Update Post Date:
2014-07-18
Last Update Post Date Type:
ESTIMATED